Here are relevant reports on : bariatric-surgical-procedures-market
-
Surgical Anastomosis Devices Market by Product, (Surgical Sutures, Surgical Staplers), Application (Cardiovascular, Gastrointestinal) - Global Forecast to 2023
Anastomosis is a connection made surgically between adjacent blood vessels, parts of the intestine, or other channels of the body. It is achieved by surgically suturing or stapling the two ends of the channel to restore or form a new connection. Vascular anastomosis is performed to connect the blood vessels, for e.g. in cardio vascular surgeries such as by-pass surgery. Similarly, gastrointestinal anastomosis is performed for bowel re-sectioning, for e.g. in Gastrojejunostomy. With increasing ailments of cardiovascular diseases, gastrointestinal surgeries, and organ transplants has resulted in demand for anastomosis devices.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Anastomosis Devices Market by Product, Surgical Staplers (Manual, Powered), Surgical Sutures (Absorbable, Non-absorbable, Automated), and Surgical Sealants and Adhesives, Application (CVDs, GI Surgeries), End Users & Region - Global Forecast to 2027
The global anastomosis devices market in terms of revenue was estimated to be worth $3.0 billion in 2022 and is poised to reach $4.4 billion by 2027, growing at a CAGR of 8.3% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: August 2022
- Price: $ 4950
- TOC Available:
-
Surgical Products Market by Product (Surgical Suture & Stapler, Handheld Surgical Devices (Forceps & Spatula, Retractor, Dilator, Auxiliary Device)), Electrosurgical, Arthroscopic Instruments, Application (Plastic, Cardiovascular, Laparoscopy, Surgery), End User - Global Forecast to 2022
The global surgical products market is expected to reach USD 26.57 Billion by 2022 from USD 28.91 Billion in 2017, growing at a CAGR of 7.4% from 2017 to 2022. Rising incidence and prevalence of acute and chronic diseases, ready availability of surgical products, and growing demand for minimally invasive procedures are some of the major driving factors driving the growth of the global surgical products market. However, the high cost of surgical procedure and challenges in reimbursement are hindering the growth of this market to a certain extent.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Lithotripsy Devices Market by Type (ESWL, Intracorporal (Laser, Electrohydraulic, Mechanical, Ultrasonic Lithotripsy)), Application (Kidney, Ureteral, Bile Duct & Pancreatic Stones), End User (Hospital), Procedures - Global Forecast to 2023
The global lithotripsy devices market is expected to reach USD 1.76 Billion by 2023, at a CAGR of 4.5%. Growth in this market is propelled by the increasing incidence of urolithiasis and technological advancements in lithotripsy devices. Some of the major players in the lithotripsy devices market are Siemens AG (Germany), Boston Scientific (US), Dornier MedTech (Germany), Olympus America (Japan), DirexGroup (Germany), and Richard Wolf (Germany). Key companies in the Lubricating Oil Additives market include Afton Chemical (US), Chevron Oronite (US), BASF (Germany), Evonik Industries (Germany), Lubrizol Corporation (US), and Lanxess (Germany).
- Published: June 2018
- Price: $ 4950
- TOC Available:
-
Orthopedic Devices Market by Product (Fixation, Replacement, Prosthetics, Spinal Implant, Brace, Orthobiologics (DBM), Bone Graft), Procedures Volume (Knee, Hip, Ankle, Shoulder) Site, Application, End User (Hospital, ASC, Trauma) - Global Forecast to 2030
The global orthopedic devices market, valued at US$49.63 billion in 2023, stood at US$51.61 billion in 2024 and is projected to advance at a resilient CAGR of 4.8% from 2024 to 2030, culminating in a forecasted valuation of US$68.51 billion by the end of the period. The primary driver of the market is the increasing prevalence of orthopedic disorders, especially in the geriatric population. The growth is also propelled by efforts by the market leaders in terms of new product launches for orthopedic devices.
- Published: March 2025
- Price: $ 12000
- TOC Available:
-
European Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET - F-18), Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90)), Application (Oncology, Thyroid, Cardiology), Procedures - Forecasts to 2020
Over the years, the European nuclear medicine/radiopharmaceuticals market has witnessed various advancements in radiopharmaceuticals. The European radiopharmaceuticals market is witnessing growth owing to an increasing number of radioisotope approvals for different clinical indications. Tc-99m and F-18 radioisotopes are estimated to contribute the highest to the European nuclear medicine diagnostic market in 2015, whereas Ra-223, I-131 and Y-90 ensured their leading position in the therapeutic market. The European nuclear medicine/radiopharmaceuticals market is expected to reach $1.62 Billion by 2020 from $1.09 Billion in 2015, growing at a CAGR of 8.2% from 2015 to 2020.
- Published: November 2015
- Price: $ 4950
- TOC Available:
-
US Therapeutic Plasma Exchange Market by Product (Devices, Consumables), Technology (Centrifugation, Membrane Separation), Procedures & Patients (Guillain Syndrome, Multiple Sclerosis, Cryoglobulinemia), End Users & Region - Forecast to 2025
The US therapeutic plasma exchange (TPE) market, valued at $178 million in 2020, is projected to grow to $243 million by 2025, with a CAGR of 6.3%. Growth is fueled by increasing chronic disease prevalence and technological advancements, especially in continuous-flow centrifugation. However, high device costs and a shortage of skilled professionals may hinder growth.
- Published: September 2020
- Price: $ 4950
- TOC Available:
-
Interventional Radiology Imaging Market by Product (MRI System, Ultrasound Imaging System, CT Scanner, Angiography System), Procedures (Angiography, Angioplasty, Biopsy) & Application (Cardiology, Oncology, Urology & Nephrology) - Global Forecast to 2021
The global interventional radiology imaging market is projected to grow at a CAGR of 6.7%. This market is segmented based on product, procedure, and application. A number of factors, such as rising incidence and prevalence of chronic diseases, increasing demand for minimally invasive procedures, technological advancements are expected to drive the growth of this market.
- Published: March 2017
- Price: $ 4950
- TOC Available:
-
Pediatric Interventional Cardiology Market By Congenital Heart Defect Closure Device [ASD, Ventricular Septal Defect, Patent Ductus Arteriosus, Left Atrial Appendage, Aortic Valve, Pulmonary Valve] & Procedures – Global Forecasts to 2018
The global pediatric interventional cardiology market is segmented on the basis of type of devices and geography. Based on the type of device, the market is further segmented into congenital heart defect closure devices, transcatheter heart valves, and others (catheters, guidewires, balloons, and stents). Based on geography, this market is divided into four geographic regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW). This report also includes the number of pediatric interventional cardiology procedures performed across different regions.
- Published: March 2014
- Price: $ 4950
- TOC Available:
-
Hybrid Operating Room Market by Component (Surgical Booms, Surgical Lights, Operation Tables, MRI, CT, Angiography, AV Tools), Application (Cardiovascular, Neurovascular, Thoracic, Orthopedic), End User, and Region - Global Forecast to 2022
The global hybrid operating room market is expected to reach USD 1,174.9 Million by 2022 from USD 652.0 Million in 2017; growing at a CAGR of 12.5% during the forecast period. As of 2016, the major product manufacturers operating in the global hybrid operating room market included Philips Healthcare (The Netherlands), Siemens Healthineers (Germany), Stryker Corporation (U.S.), Toshiba Corporation (Japan), GE Healthcare (U.S.), IMRIS Inc. (U.S.), Eschmann Equipment (U.K.), MAQUET GmbH (Germany), Trumpf Medical (Germany), and Skytron LLC (U.S.), among others.
- Published: August 2017
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
